New Diagnosis? Start Here

News

RSS

April 2, 2016

Researchers from the University of Costa Rica and the University of Glasgow teamed up to investigate the DNA mutation causing myotonic dystrophy type 1 (DM1). They found that polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. 

April 2, 2016

Dr. John Porter, former Program Director of Neuromuscular Disease at the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), has joined MDF as its Interim Chief Science Officer. Dr. Sharon Hesterlee, who formerly filled this position, will remain active as a member of MDF’s Scientific Advisory Committee.

March 10, 2016

Dr. Charles Thornton, neurologist at the University of Rochester Medical Center and MDF Scientific Advisory Committee member, has been awarded a Javits Neuroscience Investigator Award from the National Institutes of Health to further his research on muscular dystrophy. Read more about this very distinguished award for “exceptional” investigators and the important work Dr. Thornton is doing here.

March 10, 2016

Our new Program Director Paul Formaker is ready and waiting to take your calls. His favorite part of the job is answering our Warmline, sharing support and resources for living with DM. If you're interested, he might even entertain you with a song! Read this article for more information on the MDF Warmline and our man behind the phones.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.